BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Frank Hilberg(Boehringer Ingelheim (Austria)), Wolfgang J. Rettig(Boehringer Ingelheim (Austria))
Cited by 1,056
Related Papers
Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts
|Journal of Biological Chemistry|1999|573
Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases
|Journal of Pharmacology and Experimental Therapeutics|2017|105